Svetlana Mojsov to deliver this year’s Nicholson Lecture

The lecture will take place at 16:00 in Nobel Forum, Campus Solna. In her talk,“GLP‑1: From a Putative Peptide to Effective Medicines for Diabetes and Obesity”, Mojsov will present the scientific discoveries behind today’s GLP‑1–based therapies, which are widely used to treat type 2 diabetes and obesity. The event will be followed by a reception.

Svetlana Mojsov is a biochemist at Rockefeller University whose research focuses on how peptides and small proteins regulate physiological processes in health and disease. She played a key role in the discovery and characterisation of glucagon‑like peptide‑1 (GLP‑1), a hormone that stimulates insulin secretion and regulates glucose metabolism. Her work laid the foundation for a new class of medicines that has transformed the treatment of diabetes and obesity and is now used by millions of patients worldwide.

Mojsov holds a degree in physical chemistry from the University of Belgrade and a PhD in biochemistry from Rockefeller University, where she worked with Nobel laureate Bruce Merrifield on peptide synthesis. In the early 1980s, she demonstrated that a fragment of GLP‑1 functions as an incretin hormone—an insight that proved crucial for understanding glucose regulation and for the development of modern GLP‑1–based therapies.